Program
Theme
“Global Virology 2026: Deep Science for Emerging Threats”
As viral threats continue to emerge and spread across borders, advancing fundamental virology through global collaboration is more important than ever. This program highlights cutting-edge basic science and connects it to real-world impact, bringing together leading researchers from around the world to share insights and drive innovation.
Spanning diverse fields—from host–virus interactions and data science to vaccine development and pandemic preparedness—the program fosters interdisciplinary exchange and international partnership. By integrating knowledge across human, animal, and environmental virology, we aim to deepen scientific understanding and accelerate solutions for global health challenges.
Timetable
Plenary Lecture 1
2 November 13:50-14:50 Room1
「TMPRSS2-mediated coronavirus spike activation and inhibition」
Chair: Kei Sato（Division of Systems Virology, The Institute of Medical Science, The University of Tokyo）
Speaker: Dr. David Veesler（University of Washington）
Plenary Lecture 2
3 November 14:10-15:10 Room1
「Hepatoviruses in the Twenty-first Century」
Chair: Takaji Wakita（Japan Institute of Health Security）
Speaker: Dr. Stanley M. Lemon（The University of North Carolina at Chapel Hill）
Special Lecture
3 November 11:00-12:00 Room1
「Preparing for the Next Pandemic: Issues and Challenges」
Chair: Tomoya Saito（Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Japan Institute for Health Security）
Speaker: Hitoshi Oshitani（Department of Global Health and Infectious Diseases, Tohoku University Graduate School of Medicine）
Symposium 1
Symposium of the Japan Initiative for World-leading Vaccine Research and Development Centers
AMED-SCARDA
Japan Initiative for World-leading Vaccine Research and Development Centers
2 November 9:00-12:00 Room1
Chair
Yoshihiro Kawaoka（Department of Virology, University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center）
Takeshi Kobayashi（Department of Virology, Research Institute for Microbial Diseases, The University of Osaka）
Development of SFTS vaccine
Speaker: Jiro Yasuda（CCPID, Nagasaki University）
Mucosal Secretory IgA Antibody as an Immune Correlate for Controlling Respiratory Viral Shedding
Speaker: Tadaki Suzuki（Graduate School of Medicine, Chiba University／National Institute of Infectious Diseases, Japan Institute for Health Security）
Resolving heterogeneous infection states within a virus microenvironment
Speaker: Ileana M. Cristea（Department of Molecular Biology, Princeton University）
Insights on antiviral immunity from dengue vaccine development
Speaker: Eng Eong Ooi（Programme in Emerging Infectious Diseases, Duke-NUS Medical School）
Symposium 2
Control of endemic HTLV-1 to prevent silent global spread
AMED-ASPIRE
2 November 9:15-11:30 Room2
Chair
Tetsuro Matano（National Institute of Infectious Diseases, Japan Institute for Health Security）
Damian Purcell（Department of Microbiology and Immunology at the Doherty Institute, University of Melbourne）
HTLV-1c associated morbidity and mortality in Australia
Speaker: Lloyd Einsiedel（Department of Microbiology and immunology, University of Melbourne）
HTLV-1 Infection in Japan and Australia: Virological Insights into Viral Diversity and Pathogenesis
Speaker: Yorifumi Satou （Department of Microbiology and Immunology, Faculty of Medicine, Hokkaido University／Joint Research Center for Human Retrovirus Infection, Kumamoto University）
Australian HTLV-1c has distinctive virology and immunopathogenesis relative to HTLV-1a from Japan, but common opportunities to prevent infection and disease.
Speaker: Damian Purcell （Department of Microbiology and Immunology at the Doherty Institute, University of Melbourne）
Integrated genomic and epigenomic analysis for therapeutic target discovery in HTLV-1-associated diseases
Speaker: Makoto Yamagishi（Graduate School of Frontier Sciences, University of Tokyo）
Symposium 3
Women Shaping the Future of Virology
AMED-ASPIRE
2 November 14:55-17:00 Room1
Chair
Asuka Nanbo（Department of Virus Infection Dynamics, National Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University）
Kanako Kimura（Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University）
Virological characteristics of novel SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia
Speaker: Wilaiporn Saikruang（Division of Systems Virology, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo）
The diagnoses that we miss: next-generation sequencing and serology for emerging virus detection
Speaker: Emma Thomson（MRC-University of Glasgow Centre for Virus Research）
At the Site of Entry: Mucosal Immune Responses and Protection Against Respiratory Viruses
Speaker: Neeltje van Doremalen（Laboratory of Virology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, NIAID, NIH）
Revealing principles of filovirus nucleocapsid assembly through comparative in situ structural analyses of Ebola and Marburg viruses
Speaker: Reika Watanabe（Center for Vaccine Innovation, La Jolla Institute for Immunology）
Respiratory Organoids: A Robust Platform for Evaluating Virus Infectivity and Developing Therapeutics
Speaker: Jie ZHOU, Jane（Department of Microbioloy, The University of Hong Kong／BiomOrgan Limited）
Symposium 4
The crowded cell: Molecular regulation and conflict shaping viral life cycles in plants, fungi, and insects
2 November 14:55-16:55 Room2
Chair
Tomofumi Mochizuki（Graduate School of Agriculture, Osaka Metropolitan University）
Kazuhiro Ishibashi（Institute of Agrobiological Sciences, National Agriculture and Food Research Organizations）
Alphavirus RNA Translation-to-Replication Transition
Speaker: Masaki Nishikiori（John W. and Jeanne M. Rowe Center for Research in Virology, Morgridge Institute for Research／Institute for Molecular Virology, University of Wisconsin-Madison／McArdle Laboratory for Cancer Research, University of Wisconsin-Madison）
Mechanistic insights into satellite RNA–mediated interference of plant viral replication
Speaker: Na-Sheng Lin（Institute of Plant and Microbial Biology, Academia Sinica）
Mechanisms of RNA viruses endomembrane hijacking, plant perception and mitigation strategies
Speaker: Marion Clavel（Max Planck Institute for Molecular Plant Physiology）
Impacts of molecular parasites on fungal pathogen evolution
Speaker: Yukiyo Sato （Institute of Plant Science and Resources, Okayama University）
［Cosponsored by the Federation of Microbiological Societies of Japan］
Symposium 5
New Frontiers in Host-Virus Interactions
US-Japan Cooperative Medical Sciences Program
3 November 9:00-10:55 Room1
Chair
Hiroyuki Yamamoto（AIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security）
Hideki Hasegawa（Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security）
Unraveling the mechanisms of pathogenicity using hemorrhagic fever viruses in a biosafety level-4 facility.
Speaker: Junki Maruyama（Department of Pathology, The University of Texas Medical Branch at Galveston）
Targeting CCR5 in HIV Cure
Speaker: Jonah Sacha（Division of Pathobiology & Immunology, Oregon Health & Science University）
iHALT: Liver as a surrogate secondary lymphoid organ
Speaker: Arash Grakoui（Emory University School of Medicine）
Molecular determinants of the North American H5N1 virus for immune cell tropism and systemic dissemination
Speaker: Young Ki CHOI （Center for Study of Emerging and Re-emerging Viruses, Korea Virus Research Institute, Institute for Basic Science／Virus Research Resource Center, Korea Virus Research Institute, Institute for Basic Science／Department of Metabiohealth, Sungkyunkwan University）
Symposium 6
USJCMSP Hepatitis Panel: Achievement and Future Challenges in Hepatitis Research
3 November 15:15-17:45 Room1
Chair
Eui-Cheol Shin（Korea Advanced Institute of Science and Technology）
Sachiyo Yoshio（National Institute of Global Health and Medicine, Japan Institute for Health Security Department of Human Immunology and Translational Research）
Therapeutic HBV vaccine efficacy through ancestral mismatched T cell epitopes
Speaker: Nina Le Bert（Program in Emerging Infectious Diseases, Duke-NUS Medical School）
Mechanistic Insights into CD8+ T-Cell Tolerance in HBV-Expressing Livers - Multiple Paths to Dysfunction
Speaker: Keigo Kawashima（Department of Virology II, National Institute of Infectious Diseases, Japan Institute for Health Security／Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security）
Targeting NTCP for HBV and HDV infection: development of susceptible cell lines and Small-Molecule Discovery
Speaker: Chunkyu Ko（Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology）
Fumarylacetoacetate Hydrolase as a Novel Host Factor Regulating HBV Replication and the Antiviral Potential of Dimethyl Fumarate
Speaker: Takuto Nosaka（Department of Gastroenterology, Faculty of Medical Sciences, University of Fukui）
Chair
Motoyuki Otsuka（Department of Gastroenterology and Hepatology, Academic Fields of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University）
Toru Okamoto（Department of Virology, Juntendo University School of Medicine）
The immunological and structural basis of hepaciviral adaptation
Speaker: John Gridley（Emory University）
RNA decay, innate Immunity, and the control of hepatitis D virus infection
Speaker: Senko Tsukuda（Chinese Academy of Medical Sciences Oxford Institute, University of Oxford／National Institute of Infectious Diseases, Japan Institute for Health Security）
Single-cell landscape of immune responses in patients with acute hepatitis A virus infection
Speaker: Hosun Yu（Graduate School of Medical Science and Engineering, KAIST）
Concluding Remarks
Tatsuya Kanto（The Research Center for Hepatitis and Immunology, National Institute of Global Health and Medicine, Japan Institute for Health）
Arash Grakoui（Emory University School of Medicine）
Symposium 7
Satellite symposium of France-Japan HIV/AIDS and Infectious Disease Basic and Translational Research
Organizing committee for the 4th France-Japan Symposium on HIV/AIDS and Infectious Disease Basic and Translational Research, National Institute of Infectious Diseases, JIHS
4 November 9:00-12:00 Room1
Opening Remarks
Ai Kawana-Tachikawa（AIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security）
Michaela Müller-Trutwin（Institut Pasteur）
Anavaj Sakuntabhai （Department of Global Health, Institut Pasteur）
Chair
Michaela Müller-Trutwin（Institut Pasteur）
Ai Kawana-Tachikawa（AIDS Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security）
Enteric viral infections accelerate aging in Drosophila
Speaker: Carla SALEH（Department of Virology, Institut Pasteur）
Targeting HIV-1 through structural control of the viral capsid
Speaker: Shinichi Machida（National Institute of Global Health and Medicine, Japan Institute for Health Security）
Rational Design of Next-Generation CD8 T-Cell Vaccines for Viral Control
Speaker: Takuya Yamamoto（Center for Intractable Diseases and ImmunoGenomics, NIBN）
Persistent infection with the herpesvirus CMV affects responsiveness to anti-viral heterologous vaccination in older adults
Speaker: Victor Appay（ImmunoConcept – Université de Bordeaux）
Infectious Disease Pathology in Emerging Tick-Borne Viral Infections
Speaker: Tadaki Suzuki（National Institute of Infectious Diseases, Japan Institute for Health Security／Graduate School of Medicine, Chiba University）
Temperature-Dependent Replication and Sensitivity to Innate Immunity of Human Coronavirus HKU1 in primary respiratory cells and in cell lines
Speaker: Olivier Schwartz（Department of Virology, Institut Pasteur）
Symposium 8
Zoonotic Influenza and Pandemic Preparedness: At The Frontline
4 November 13:15-15:15 Room1
Chair
Hideki Hasegawa（Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security）
Yoshihiro Sakoda（Laboratory of Microbiology, Faculty of Veterinary Medicine, Hokkaido University）
Advancing wild-bird surveillance for high pathogenicity avian influenza viruses through environmental water sampling
Speaker: Makoto Ozawa（Kagoshima University）
Genetic diversity of H5 subtype High Pathogenicity Avian Influenza virus isolated from poultry and wild birds in Japan and differences of susceptibility in birds
Speaker: Yuko Uchida（National Agriculture and Food Research Organization, National Institute of Animal Health）
Host range expansion and cross-species transmission of H5 high pathogenicity avian influenza viruses in wildlife ecosystems in Hokkaido, Japan
Speaker: Yoshihiro Sakoda（Faculty of Veterinary Medicine, Hokkaido University／One Health Research Center, Hokkaido University／International Institute for Zoonosis Control, Hokkaido University／Hokkaido University Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University）
From Markets to Mammals: Tracking Cambodia’s Reassortant H5N1 at the Spillover Interface
Speaker: Erik Albert Karlsson（Institut Pasteur）
Avian influenza : integrating host ecology, virology and epidemiology to characterise and manage risk.
Speaker: Nicola Sarah Lewis（Worldwide Influenza Centre, WHO CC for Influenza Reference and Research, Francis Crick Institute／Royal Veterinary College, University of London）
Symposium 9
Data Science for Virology: From Models to Real-World Impact
Moonshot R&D Program Goal 2 Realization of ultra-early disease prediction and intervention by 2050.
Understanding and Control of Virus-Human Interaction Networks
4 November 15:20-17:20 Room1
Chair
So Miyoshi（Clinical Pharmacology and Bioanalytics, Pfizer R&D Japan）
Shingo Iwami（Graduate School of Science, Nagoya University）
Quantitative Systems Pharmacology and Model-Informed Drug Development for Anti-Viral Drugs and Vaccines
Speaker: Richard Allen（Translational Clinical Sciences, Pfizer Inc.）
Optimal virologic endpoint selection allows efficient, rapid and small early phase trials for respiratory virus targeting antiviral agents
Speaker: Joshua T. Schiffer（Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer／Department of Medicine, University of Washington）
Translating individual-level variation in susceptibility into population-level epidemic dynamics
Speaker: Fuminari Miura（Dutch National Institute for Public Health and the Environement (RIVM)／Leiden University Medical Centre (LUMC)／Nagasaki University）
A Quantitative Framework for Droplet-Mediated Transmission in Respiratory Viral Infections
Speaker: Yong Dam Jeong（Department of Applied Mathematics, Pukyong National University／interdisciplinary Biology Laboratory, Division of Biological Science, Graduate School of Science, Nagoya University）
Symposium Organized by the Vaccine Committee
Recent Advances in Vaccination Strategies for the Prevention of Viral Infections
2 November 14:55-16:55 Room3
Chair
Tetsushi Yoshikawa（Fujita Health University School of Medicine）
Tetsuro Matano（National Institute of Infectious Diseases, Japan Institute for Health Security）
Protecting Infants and Toddlers from RSV: Vaccines and Antibody Therapies
Speaker: Koichi Hashimoto（Fukushima Medical University）
Resurrection of MMR after 30 years: backgroud and future
Speaker: Tetsuo Nakayama（Kitasato University）
Expanding Options for Influenza Vaccination
Speaker: Hideki Hasegawa（Japan Institute for Health Security National Insititute of Infectious Diseases）
Herpes Zoster and Dementia: VZV Reactivation and the Potential Preventive Role of Vaccination
Speaker: Jun-ichi Kawada（Department of Pediatrics, Fujita Health University School of Medicine）
Workshops
1. Host Recognition and Infection
2. Replication and Assembly
3. Genome, Technology, and Models
4. Pathogenesis and Immunity
5. Prevention, Therapy, and Control
6. Infectious Disease Research Network in Asia
General Presentations
Oral and poster presentations will be organized based on submitted abstracts.
Educational Seminars & Exhibitions
Luncheon seminars, corporate exhibitions, and related programs will be held.